secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2026-05-01T23:59:59+00:00
Accession:  0001628280-26-029323
Event type: litigation
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics resolves stockholder class action; $850K mootness fee paid by third party
--------------------------------------------------------------------------------

- Delaware court invalidated classified board and for-cause removal provisions from charter.
- Third-party service provider agreed to pay $850,000 mootness fee; company did not pay.
- Fee paid May 1, 2026; action to close after annual meeting scheduled June 24, 2026.
- Stipulated order granted April 30, 2026; court retains jurisdiction only for mootness fee application.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000162828026029323/0001628280-26-029323-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000162828026029323/cntx-20260430.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-029323

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer